Orient Pharma Co., Ltd.
TWO: 4166.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chun-Tong Huang
- Employees
- 173
- Headquarters
- Taipei, Taiwan
- IPO year
- 2012
- Market cap
- NT$6.3B
- Website
- https://www.oppharma.com
Loading 4166…
Loading profile data…Frequently asked questions about 4166
What does Orient Pharma Co., Ltd. (4166.TWO) do?
Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperact...
Where does 4166.TWO trade?
Orient Pharma Co., Ltd. (4166.TWO) trades on the Taipei Exchange.
What sector is 4166.TWO in?
Orient Pharma Co., Ltd. (4166.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Orient Pharma Co., Ltd.?
Chun-Tong Huang is the chief executive officer of Orient Pharma Co., Ltd. (4166.TWO).
Where is Orient Pharma Co., Ltd. headquartered?
Orient Pharma Co., Ltd. is headquartered in Taiwan.
Does 4166.TWO pay a dividend?
Orient Pharma Co., Ltd. (4166.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4166.TWO go public?
Orient Pharma Co., Ltd. (4166.TWO) completed its initial public offering in 2012.